SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Adamis Pharmaceuticals Corporation (ADMP), a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology, announced that a court entered an order of dismissal with prejudice of a complaint filed against Adamis regarding a dispute over one of its license agreements, resolving the case in Adamis' favor.
That's it? After more than a year of no PRs this is all they have to say?? Holy #$%$ that's pathetic. I thought they were a biopharma co. with clinical development activities ongoing. They couldn't come up with one PR relevant to the clinical progress or some other relevant business activity? An update on some stupid court ruling is just a huge slap in the face to long term shareholders. Unbelievable!